
Project Lead: Judit Erdös
Authors: Judit Erdös, NN
Duration: fromQ4 2026 (ongoing)
Language: English
Since January 2025, the implementation of the HTA Regulation (HTA-VO) has been mandatory. Starting in January 2026, the clinical added benefit of selected high-risk medical devices must be evaluated through joint European assessments (Joint Clinical Assessments/JCA).
AIHTA is planning to conduct JCAs for medical devices.